Ludmila F M F Cardozo1, Milena B Stockler-Pinto1, Denise Mafra1,2. 1. Graduate Program in Cardiovascular Sciences, Universidade Federal Fluminense (UFF), Niterói-Rio de Janeiro, Brazil. 2. Graduate Program in Medical Sciences, Universidade Federal Fluminense (UFF), Niterói-Rio de Janeiro, Brazil.
Abstract
SCOPE: Previous studies showed that the supplementation with Brazil nut is effective in improving Se status, reduce oxidative stress, and inflammation in hemodialysis (HD) patients. As the nutritional compounds may promote the reduction of inflammation by activation of nuclear factor E2-related factor 2 (Nrf2), the aim of this pilot study was to evaluate the effects of Brazil nut supplementation on Nrf2 activation in HD patients. METHODS AND RESULTS: Thirteen HD patients received one Brazil nut supplementation per day for 3 months and were compared to 12 HD patients without supplementation. Peripheral blood mononuclear cells were isolated and processed for expression of nuclear factor kappa B, Nrf2, and NAD(P)H: quinone oxidoreductase 1 (NQO1) by quantitative real-time PCR. Plasma malondialdehyde, C-reactive protein and IL-6 levels were measured before and after supplementation. The Nrf2 expression increased and nuclear factor kappa B expression reducedpost supplementation. In addition, the cytokines and malondialdehyde levels decreased significantly. No significant alterations were found in the control group. CONCLUSION: This preliminary result indicates the effectiveness of Brazil nut supplementation on human Nrf2 activation in HD patients and could be a possible explanation for the beneficial effects of this nut as a bioactive compound.
SCOPE: Previous studies showed that the supplementation with Brazil nut is effective in improving Se status, reduce oxidative stress, and inflammation in hemodialysis (HD) patients. As the nutritional compounds may promote the reduction of inflammation by activation of nuclear factor E2-related factor 2 (Nrf2), the aim of this pilot study was to evaluate the effects of Brazil nut supplementation on Nrf2 activation in HDpatients. METHODS AND RESULTS: Thirteen HDpatients received one Brazil nut supplementation per day for 3 months and were compared to 12 HDpatients without supplementation. Peripheral blood mononuclear cells were isolated and processed for expression of nuclear factor kappa B, Nrf2, and NAD(P)H: quinone oxidoreductase 1 (NQO1) by quantitative real-time PCR. Plasma malondialdehyde, C-reactive protein and IL-6 levels were measured before and after supplementation. The Nrf2 expression increased and nuclear factor kappa B expression reducedpost supplementation. In addition, the cytokines and malondialdehyde levels decreased significantly. No significant alterations were found in the control group. CONCLUSION: This preliminary result indicates the effectiveness of Brazil nut supplementation on humanNrf2 activation in HDpatients and could be a possible explanation for the beneficial effects of this nut as a bioactive compound.
Authors: Barbara R Cardoso; Ewa A Szymlek-Gay; Blaine R Roberts; Melissa Formica; Jenny Gianoudis; Stella O'Connell; Caryl A Nowson; Robin M Daly Journal: Nutrients Date: 2018-12-01 Impact factor: 5.717
Authors: Denise Mafra; Ludmila F M F Cardozo; Cristiane Moraes; Lais S G Moreira; Karla T R Teixeira; Drielly C M V Reis; Susane Fanton; Roberta Salarolli; Kamyar Kalantar-Zadeh; Jerrilynn D Burrowe Journal: J Ren Nutr Date: 2020-08-18 Impact factor: 3.655